Dana Farber Cancer Institute /ID# 148475

Boston, Massachusetts 02215

We've found

1 trials

at this facility

A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification

Status: Enrolling, Phase II, III
Updated: 12/31/1969

from

Boston, MA

Use our guide to learn which trials are right for you!